# REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study

> **NCT06108427** · NA · RECRUITING · sponsor: **Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal** · enrollment: 58 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **OTHER:** Renin measurements

## Key facts

- **NCT ID:** NCT06108427
- **Lead sponsor:** Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-25
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06108427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06108427, "REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06108427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*